BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27717414)

  • 1. Overview of Laboratory Testing and Clinical Presentations of Complement Deficiencies and Dysregulation.
    Frazer-Abel A; Sepiashvili L; Mbughuni MM; Willrich MA
    Adv Clin Chem; 2016; 77():1-75. PubMed ID: 27717414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
    Yuan X; Gavriilaki E; Thanassi JA; Yang G; Baines AC; Podos SD; Huang Y; Huang M; Brodsky RA
    Haematologica; 2017 Mar; 102(3):466-475. PubMed ID: 27810992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement deficiencies and dysregulation: Pathophysiological consequences, modern analysis, and clinical management.
    Schröder-Braunstein J; Kirschfink M
    Mol Immunol; 2019 Oct; 114():299-311. PubMed ID: 31421540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical aspects of the complement system].
    Tsukamoto H; Horiuchi T
    Rinsho Byori; 2006 Jul; 54(7):757-62. PubMed ID: 16913667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of complement deficiencies.
    Pettigrew HD; Teuber SS; Gershwin ME
    Ann N Y Acad Sci; 2009 Sep; 1173():108-23. PubMed ID: 19758139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hereditary and acquired deficiencies of complement.
    Nusinow SR; Zuraw BL; Curd JG
    Med Clin North Am; 1985 May; 69(3):487-504. PubMed ID: 3892188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn.
    Hallstensen RF; Bergseth G; Foss S; Jæger S; Gedde-Dahl T; Holt J; Christiansen D; Lau C; Brekke OL; Armstrong E; Stefanovic V; Andersen JT; Sandlie I; Mollnes TE
    Immunobiology; 2015 Apr; 220(4):452-9. PubMed ID: 25468724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs that inhibit complement.
    Schrezenmeier H; Höchsmann B
    Transfus Apher Sci; 2012 Feb; 46(1):87-92. PubMed ID: 22169380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are complement deficiencies really rare? Overview on prevalence, clinical importance and modern diagnostic approach.
    Grumach AS; Kirschfink M
    Mol Immunol; 2014 Oct; 61(2):110-7. PubMed ID: 25037634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hereditary complement deficiencies].
    Fischer E
    Hautarzt; 1982 Feb; 33(2):65-72. PubMed ID: 6281215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management.
    Brodszki N; Frazer-Abel A; Grumach AS; Kirschfink M; Litzman J; Perez E; Seppänen MRJ; Sullivan KE; Jolles S
    J Clin Immunol; 2020 May; 40(4):576-591. PubMed ID: 32064578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-complement therapy for glomerular diseases.
    Bomback AS
    Adv Chronic Kidney Dis; 2014 Mar; 21(2):152-8. PubMed ID: 24602464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and future pharmacologic complement inhibitors.
    Risitano AM
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):561-82. PubMed ID: 26043392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement Dysregulation and Disease: Insights from Contemporary Genetics.
    Liszewski MK; Java A; Schramm EC; Atkinson JP
    Annu Rev Pathol; 2017 Jan; 12():25-52. PubMed ID: 27959629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory tests for disorders of complement and complement regulatory proteins.
    Shih AR; Murali MR
    Am J Hematol; 2015 Dec; 90(12):1180-6. PubMed ID: 26437749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies.
    Rosenfeld SI; Kelly ME; Leddy JP
    J Clin Invest; 1976 Jun; 57(6):1626-34. PubMed ID: 932197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spectrum of complement alternative pathway-mediated diseases.
    Holers VM
    Immunol Rev; 2008 Jun; 223():300-16. PubMed ID: 18613844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic complement inhibition – from experimental to clinical medicine.
    Lappegård KT; Bjerre A; Tjønnfjord GE; Mollnes TE
    Tidsskr Nor Laegeforen; 2015 Oct; 135(19):1745-9. PubMed ID: 26486669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement in autoimmune diseases.
    Vignesh P; Rawat A; Sharma M; Singh S
    Clin Chim Acta; 2017 Feb; 465():123-130. PubMed ID: 28040558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of the complement system in clinical practice].
    Frémeaux-Bacchi V; Dragon-Durey MA; Blouin J; Mouthon L; Fridman WH
    Ann Med Interne (Paris); 2003 Dec; 154(8):529-40. PubMed ID: 15037829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.